LAVONDIA EDWARDS: Open Payments
NPI 1235460163 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 7 payments from 6 companies in 2025. Trend: 2023 $1,047 · 2024 $1,182 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $220 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $145 |
| Tris Pharma Inc | 1 | $110 |
| Teva Pharmaceuticals USA, Inc. | 1 | $109 |
| Corcept Therapeutics | 1 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $61 |
Products named: Kerendia, FASENRA, Dyanavel XR, UZEDY, BREZTRI, Korlym, TZIELD.
Industry payments across MO — which companies pay providers there.
